Reference |
N° of Subjects (males) |
Age (ys) |
Characteristics |
Intervention |
Outcome |
HbA1c (%) |
Insulin doses/day |
|
|
Durak et al. [135] |
8 T1D (8) |
31 ± 3.5 |
6.9 ± 1.4 → 5.8 ± 0.9 |
46.2 ± 15 → 41.6 ± 16 IU.day-1 |
3 d/wk; 10 wks, 15 exercises (max 12 reps), 3-6 sets, rest intervals : 30s-2min. [IA/DA NA]. [PAS, PP, FS = NA]. Exercise ~ 5h after insulin injection. |
- HbA1c and glucose levels ↓ significant
|
Ramalho et al. [122] |
6 T1D (1) |
20.8 ± 4.7 |
8.2 ± 2.9 →7.6 ± 1.6 |
0.95 ± 0.3 → 0.79 ± 0.28 IU.day-1 |
3d/wk , 12 wks, 9 exercises (8-12 reps), 3 sets. [IA+, DA+]. |
- No significant differences in parameters.
- Self-monitored blood glucose levels, measured before and after each training session, show non- significant ↑.
|
Data are presented as mean ± SD; No. of Subjects (males) = total number of subjects and the number between brackets are the number of males;T1D: Type 1 Diabetes;
[VP]: Venous Plasma; [C]: Capillary; FGL: Fasting Glycaemic Level; IA: Insulin Advice before/after Exercise; DA: Dietary Advice before/during or after Exercise; ↓: Decrease;
[PAS]: Post Absorptive State (5-11h after last meal); [PP]: Post Prandial (during 4h after meal); [FS]: Fasting State (> 12h after meal); HbA1c : Glycaeted Haemoglobin |